financetom
Business
financetom
/
Business
/
Lemaitre Vascular Insider Sold Shares Worth $999,173, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lemaitre Vascular Insider Sold Shares Worth $999,173, According to a Recent SEC Filing
Aug 13, 2025 2:38 PM

05:12 PM EDT, 08/13/2025 (MT Newswires) -- David B Roberts, Director, President, on August 11, 2025, sold 10,815 shares in Lemaitre Vascular ( LMAT ) for $999,173. Following the Form 4 filing with the SEC, Roberts has control over a total of 17,976 common shares of the company, with 17,976 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1158895/000143774925026575/xslF345X05/rdgdoc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chemours to Benefit From Regulation on Refrigerants as Demand Improves, UBS Says
Chemours to Benefit From Regulation on Refrigerants as Demand Improves, UBS Says
Jul 9, 2024
02:57 PM EDT, 07/09/2024 (MT Newswires) -- Chemours' ( CC ) low share valuation and conservative estimates are expected to pivot as earnings in TiO2 return to normal and demand for refrigerants improves by 2025, UBS said in a note Tuesday. We expect the near-term will remain choppy, and see 2024 as a transition year for the company, the firm...
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Eli Lilly's $3.2B Morphic Deal Is 'Crucial,' Has 'Strategic Merit' Despite Investor Attention On Obesity: Analyst
Jul 9, 2024
Eli Lilly And Co ( LLY ) agreed to acquire Morphic Holding Inc ( MORF )  for $57 per share in cash, an aggregate of approximately $3.2 billion. Lead asset MORF-057 is a small-molecule inhibitor that is currently in Phase 2b trial for ulcerative colitis, with a readout expected in the first half of 2025. It recently initiated a Phase 2 study in Crohn’s disease. Also...
Cosmos Health to Manufacture 500,000 Units of CBD Products For Australian Firm
Cosmos Health to Manufacture 500,000 Units of CBD Products For Australian Firm
Jul 9, 2024
02:56 PM EDT, 07/09/2024 (MT Newswires) -- Cosmos Health ( COSM ) said Tuesday its Cana Laboratories subsidiary has secured a contract to produce 500,000 units of CBD products for Humacology, a privately held wellness company in Australia. Financial terms were not disclosed. Shares of Cosmos Health ( COSM ) were up about 1.6% in recent trading, easing from a...
Boeing Deliveries Fall Annually But Reach Highest Level This Year
Boeing Deliveries Fall Annually But Reach Highest Level This Year
Jul 9, 2024
02:55 PM EDT, 07/09/2024 (MT Newswires) -- Boeing ( BA ) reported its highest monthly deliveries of the year last month though they were down double digits year over year, while orders fell sharply. The jet maker delivered 44 planes in June, down 27% from the 60 it delivered a year ago. Last month's deliveries included 34 737 Max planes....
Copyright 2023-2026 - www.financetom.com All Rights Reserved